Further, FDA has cleared Luminex's xTAG GPP for use with specimens in Cary-Blair medium – a common transport medium for collection and preservation of microbiological specimens. xTAG GPP is a nucleic ...

xTAG GASTROINTESTINAL PATHOGEN PANEL molecular diagnostic assay by Luminex Luminex announced that it has received FDA clearance for its xTAG Gastrointestinal Pathogen Panel (GPP), a comprehensive ...

MIAMI--(BUSINESS WIRE)--Xtag, a global leader in event management and onsite registration solutions, is thrilled to announce their strategic partnership with Zoom Events, a premier platform for ...

Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new ...

Luminex Corporation (Nasdaq: LMNX), the worldwide leader in multiplexed solutions, today announced the full commercial launch of its xTAG® Cystic Fibrosis 60 Kit v2, a new diagnostic test that can ...

Luminex announced that it has launched its pharmacogenetic test, the xTAG CYP2D6 Kit, which is approved by the FDA to help identify individuals who possess both common and rare CYP2D6 poor-metabolizer ...

May 27, 2003 – Xtag, a company based in Leeds, UK, has developed a new RFID security system for tracking babies in hospital infant wards or wandering patients in elder care facilities. Xtag says its ...

Viral panel is designed to test for eight pathogens in up to 96 patients. FDA granted 510(k) approval to Luminex’ xTAG Respiratory Viral Panel FAST (RVP FAST) test for respiratory infections. Designed ...

Luminex Molecular Diagnostics has signed a global sales and distribution agreement with Abbott’s molecular diagnostics business. Under the terms of the agreement, Abbott will have exclusive rights to ...